Related references
Note: Only part of the references are listed.The State of the Art in the Development of Biosimilars
Mark McCamish et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcy receptor binding and antibody-dependent cell-mediated cytotoxicity activities
Shan Chung et al.
MABS (2012)
Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies
Yi Du et al.
MABS (2012)
The economic pressures for biosimilar drug use in cancer medicine
Paul Cornes
TARGETED ONCOLOGY (2012)
The Utility of Hydrogen/Deuterium Exchange Mass Spectrometry in Biopharmaceutical Comparability Studies
Damian Houde et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Acceptable changes in quality attributes of glycosylated biopharmaceuticals
Martin Schiestl et al.
NATURE BIOTECHNOLOGY (2011)
Advances in the assessment and control of the effector functions of therapeutic antibodies
Xu-Rong Jiang et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development
John den Engelsman et al.
PHARMACEUTICAL RESEARCH (2011)
Charge variants in IgG1 Isolation, characterization, in vitro binding properties and pharmacokinetics in rats
Leslie A. Khawli et al.
MABS (2010)
Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
Darius Ghaderi et al.
NATURE BIOTECHNOLOGY (2010)
Expression of soluble and functional human neonatal Fc receptor in Pichia pastoris
Chang-Han Lee et al.
PROTEIN EXPRESSION AND PURIFICATION (2010)
Aggregation of a multidomain protein: A coagulation mechanism governs aggregation of a model IgG1 antibody under weak thermal stress
Christian Beyschau Andersen et al.
PROTEIN SCIENCE (2010)
Analysis of Protein Conformation and Dynamics by Hydrogen/Deuterium Exchange MS
John R. Engen
ANALYTICAL CHEMISTRY (2009)
Optimal and consistent protein glycosylation in mammalian cell culture
Patrick Hossler et al.
GLYCOBIOLOGY (2009)
Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody
Boyan Zhang et al.
ANALYTICAL CHEMISTRY (2008)
Anti-inflammatory actions of intravenous immunoglobulin
Falk Nimmerjahn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope:: A carbohydrate of unique evolution and clinical relevance
Bruce A. Macher et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
Alain Beck et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose
Christine H. Chung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Enhanced binding affinity for FcγRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity
Kazuhiro Masuda et al.
MOLECULAR IMMUNOLOGY (2007)
Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody
Chris Churnsae et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Cation exchange-HPLC and mass spectrometry reveal C-terminal amidation of an IgG1 heavy chain
Keith A. Johnson et al.
ANALYTICAL BIOCHEMISTRY (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides
R Niwa et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Identification and characterization of deamidation sites in the conserved regions of human Immunoglobulin Gamma antibodies
D Chelius et al.
ANALYTICAL CHEMISTRY (2005)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
Role of oligosaccharide residues of IgG1-Fc in FcγRIIb binding
Y Mimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)